Covered recipient · General Payments record
ERIC L WOHL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2022
$2,764.30
- Reported across 172 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.35 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $138.44 | 7 |
| GlaxoSmithKline, LLC. | $16.75 | 1 |
| IBSA Pharma Inc. | $15.87 | 1 |
| Cranial Technologies, Inc | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Cranial Technologies, Inc | $14.29 | 05/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 889378251 | CMS |
| GlaxoSmithKline, LLC. | $16.75 | 07/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945004449 | CMS |
| IBSA Pharma Inc. | $15.87 | 03/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890051791 | CMS |
| Novo Nordisk Inc | $16.77 | 01/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902745609 | CMS |
| Novo Nordisk Inc | $24.01 | 01/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902745613 | CMS |
| Novo Nordisk Inc | $24.34 | 02/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902738913 | CMS |
| Novo Nordisk Inc | $21.83 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902743361 | CMS |
| Novo Nordisk Inc | $16.16 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902754671 | CMS |
| Novo Nordisk Inc | $17.67 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902745611 | CMS |
| Novo Nordisk Inc | $17.66 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902754669 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.